ELISA
The firm's next-generation pancreatic cancer test looks for five biomarkers that are indicative of early-stage disease.
Revvity's Euroimmun Gains CE Mark for Measles Assay
The firm's Anti-Measles Virus ELISA 2.0 (IgG) is used with dried blood spot samples to identify infections and determine patients' immune status.
The test measures the pancreatic stone protein biomarker to screen for sepsis and improve early detection.
Biovica Inks Master Service Agreement for Oncology-Use Cell Proliferation Assay
The firm's DiviTum TKa assay will be used in drug development studies, and the firm said the deal could lead to the development of the test as a companion diagnostic.
The automated instrument has been available for research use, but its target market will be expanded to include clinical diagnostic applications in the coming months.
May 10, 2022
OncoHost Raises $35M in Series C Financing
Mar 14, 2022
CardiNor Nabs CE Mark for Cardiovascular Risk Test
Mar 19, 2021
Mar 3, 2021
Feb 19, 2021
Feb 11, 2021
Eurofins Gets CE Mark for Coronavirus Antibody Test
Feb 10, 2021
VolitionRx Prices $20M Public Offering
Jan 4, 2021